BlackRock
TGAN

BlackRock’s Transphorm, Inc. Common Stock TGAN Stock Holding History

BlackRock’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,760,478
Closed -$8.64M – 5381
2024
Q1 		$8.64M Buy
1,760,478
+87,520
+5% +$415K ﹤0.01% 3413
2023
Q4 		$6.11M Buy
1,672,958
+229,125
+16% +$628K ﹤0.01% 3612
2023
Q3 		$3.21M Buy
1,443,833
+46,996
+3% +$131K ﹤0.01% 3842
2023
Q2 		$4.75M Buy
1,396,837
+218,615
+19% +$788K ﹤0.01% 3741
2023
Q1 		$4.7M Buy
1,178,222
+8,162
+0.7% +$35.9K ﹤0.01% 3657
2022
Q4 		$6.37M Buy
1,170,060
+70,255
+6% +$413K ﹤0.01% 3611
2022
Q3 		$5.53M Sell
1,099,805
-8,070
-0.7% -$39.7K ﹤0.01% 3713
2022
Q2 		$4.22M Buy
+1,107,875
New +$7.07M ﹤0.01% 3898

BlackRock's TGAN Position: Q2 2024 in Review

BlackRock sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 1,760,478 shares — an estimated $8.64M sold.

BlackRock first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $8.64M in Q1 2024. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • BlackRock reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 1,760,478 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $8.64M.
  • BlackRock first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • BlackRock's Transphorm, Inc. Common Stock position peaked at $8.64M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.